Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SOLARA ACTIVE PHARMA SCIENCES Gains 10%; BSE HEALTHCARE Index Up 0.8%
Fri, 28 Jun 13:45

SOLARA ACTIVE PHARMA SCIENCES Gains 10%; BSE HEALTHCARE Index Up 0.8%Image source: DNY59/www.istockphoto.com

SOLARA ACTIVE PHARMA SCIENCES share price has zoomed 10% and is presently trading at Rs 545.8.

Meanwhile, the BSE HEALTHCARE index is at 37,063.4 (up 0.8%).

Among the top gainers in the BSE HEALTHCARE index today are J.B.Chemicals (up 4.4%) and IPCA Labs (up 4.0%).

SUN PHARMA ADV. RES. (down 2.0%) and Sanofi India (down 1.6%) are among the top losers today.

Over the last one year, SOLARA ACTIVE PHARMA SCIENCES has moved up from Rs 345.0 to Rs 545.8, registering a gain of Rs 200.7 (up 58.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,266.1 to 37,063.4, registering a gain of 46.7% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Cadila Healthcare (up 91.0%), Glenmark Pharma (up 89.0%) and CAPLIN POINT (up 86.9%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 79,248.8 .

The top gainers among the BSE Sensex today are Tata Motors (up 2.3%) and Reliance Ind. (up 2.2%). The most traded stocks in the BSE Sensex are SBI and Tata Steel.

In the meantime, NSE Nifty is at 24,066.7 (up 0.1%). Dr. Reddys and ONGC are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 62,970.0 to 79,248.8, registering a gain of 16,278.8 points (up 25.9%).

SOLARA ACTIVE PHARMA SCIENCES Financial Update...

SOLARA ACTIVE PHARMA SCIENCES net profit fell 6912.0% YoY to Rs -2,555 million for the quarter ended March 2024, compared to a profit of Rs 38 million a year ago. Net sales declined 21.3% to Rs 2,994 million during the period as against Rs 3,806 million in January-March 2023.

For the year ended March 2023, SOLARA ACTIVE PHARMA SCIENCES reported 61.8% increase in net profit to Rs -223 million compared to net loss of Rs 583 million during FY22. Revenue of the company grew 13.8% to Rs 14,438 million during FY23.

The current Price to earnings ratio of SOLARA ACTIVE PHARMA SCIENCES, based on rolling 12 month earnings, stands at -4.6.


Equitymaster requests your view! Post a comment on "SOLARA ACTIVE PHARMA SCIENCES Gains 10%; BSE HEALTHCARE Index Up 0.8%". Click here!